Trying Tourette's device was the best day of my life
Summary
A wrist device developed by University of Nottingham researchers reduced tics for 15-year-old Katie, who has Tourette syndrome. A UK trial found users had an average 25% reduction in tic frequency while using a prototype, but the version intended to treat Tourette syndrome has not yet received regulatory approval.Key Facts
- Katie, from Hertfordshire, said her tics affected her sleep, eating and school attendance.
- Katie said the device calmed her symptoms when she first tried it in December.
- Neupulse delivers electrical pulses to the median nerve at the wrist.
- Researchers say rhythmic stimulation can change brain activity involved in movement control and reduce tic frequency and intensity.
- A 2023 UK clinical trial of 121 people found an average 25% reduction in tic frequency while participants used a prototype.
- Neupulse-C is sold as a consumer wellness device; Neupulse-M is intended for medical treatment but has not received regulatory approval.
- NICE has called the technology promising and requested more evidence about its long-term benefits before considering NHS adoption.
- The university said thousands of devices had been sold.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
